News
MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications
Halifax, Nova Scotia, 21st of January, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received Investigational Testing Authorizations (ITAs) from Health Canada to begin
MedMira erhält Prüfgenehmigungen für Multiplo(R) TP/HIV-Selbsttest und Anwendungen für den nicht-professionellen Gebrauch
Halifax, Nova Scotia, 21. Januar 2025 - MedMira Inc. (MedMira) (TSXV: MIR) gab heute bekannt, dass das Unternehmen von Health Canada die Investigational Testing Authorizations (ITAs)
Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report
January 15, 2025 – Vancouver, British Columbia – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is excited to
Sirona Biochem präsentiert TFC-1326 in wegweisendem Bericht von Stonegate Healthcare
15. Januar 2025 - Vancouver, British Columbia / IRW-Press / Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (OTC: SRBCF) freut sich

